{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:23:30Z","timestamp":1782516210379,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.clinthera.2019.04.026","type":"journal-article","created":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:59:28Z","timestamp":1560124768000},"page":"1240-1245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rheumatoid Arthritis: A Severe Disease That Preventive Approaches Would Greatly Benefit"],"prefix":"10.1016","volume":"41","author":[{"suffix":"III","given":"John M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.04.026_bib1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2019.04.026_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.clinthera.2019.04.013","article-title":"Nomenclature of the stages of rheumatoid arthritis development","volume":"41","author":"Raza","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.clinthera.2019.04.012","article-title":"Mucosal biology and the development of rheumatoid arthritis: potential for prevention by targeting mucosal processes","volume":"41","author":"Demoruelle","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.clinthera.2019.04.028","article-title":"Natural history of rheumatoid arthritis","volume":"41","author":"Deane","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2019.04.026_bib7","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3899\/jrheum.160103","article-title":"Longterm work productivity costs due to absenteeism and permanent work disability in patients with early rheumatoid arthritis: a nationwide register study of 7831 patients","volume":"43","author":"Martikainen","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12891-015-0562-x","article-title":"Productivity at work and quality of life in patients with rheumatoid arthritis","volume":"16","author":"van Vilsteren","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clinthera.2019.04.026_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-017-1421-y","article-title":"Large country differences in work outcomes in patients with RA\u2014an analysis in the multinational study COMORA","volume":"19","author":"van der Zee-Neuen","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/03009742.2016.1147595","article-title":"Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study","volume":"45","author":"Svensson","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14397595.2017.1416940","article-title":"Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review","volume":"28","author":"Ishida","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00296-015-3415-x","article-title":"A\u00a0structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective","volume":"36","author":"Taylor","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clinthera.2019.04.026_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/acr.22790","article-title":"Remaining pain in early rheumatoid arthritis patients treated with methotrexate","volume":"68","author":"Altawil","year":"2016","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/03009742.2018.1447683","article-title":"High prevalence of widespread pain in women with early rheumatoid arthritis","volume":"47","author":"Bilberg","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11914-018-0473-5","article-title":"Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitization","volume":"16","author":"Zhang","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.clinthera.2019.04.026_bib16","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/acr.23601","article-title":"Brain correlates of continuous pain in rheumatoid arthritis as measured by pulsed arterial spin labeling","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib17","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.clinthera.2019.04.018","article-title":"Extra-articular manifestations and comorbidity in rheumatoid arthritis: potential impact of pre-clinical rheumatoid arthritis prevention","volume":"41","author":"Giles","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/annrheumdis-2016-211066","article-title":"Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks","volume":"76","author":"Holmqvist","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3899\/jrheum.121075","article-title":"Trends in serious infections in rheumatoid arthritis","volume":"40","author":"Ni Mhuircheartaigh","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","article-title":"Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis","volume":"65","author":"Widdifield","year":"2013","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mayocp.2014.12.009","article-title":"Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota","volume":"90","author":"Michet","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2019.04.026_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/annrheumdis-2017-212131","article-title":"Mortality following new-onset rheumatoid arthritis: has modern rheumatology had an impact?","volume":"77","author":"Holmqvist","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2016-209562","article-title":"Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap","volume":"76","author":"Lacaille","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib24","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/acr.23179","article-title":"Patients' perceptions of their relatives' risk of developing rheumatoid arthritis and of the potential for risk communication, prediction, and modulation","volume":"69","author":"Falahee","year":"2017","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/02813432.2014.900239","article-title":"General practitioners' perspectives on campaigns to promote rapid help-seeking behaviour at the onset of rheumatoid arthritis","volume":"32","author":"Stack","year":"2014","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.clinthera.2019.04.026_bib26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/acr.23518","article-title":"2015 American College of Rheumatology workforce study: supply and demand projections of adult rheumatology workforce, 2015-2030","volume":"70","author":"Battafarano","year":"2018","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3899\/jrheum.160621","article-title":"Stand up and be counted: measuring and mapping the rheumatology workforce in Canada","volume":"44","author":"Barber","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12891-016-1362-7","article-title":"Improving patient flow of people with rheumatoid arthritis has the potential to simultaneously improve health outcomes and reduce direct costs","volume":"18","author":"Puchner","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clinthera.2019.04.026_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/pubmed\/fdt097","article-title":"Estimating the health-care usage associated with osteoarthritis and rheumatoid arthritis in an older adult population in Ireland","volume":"36","author":"Doherty","year":"2014","journal-title":"J\u00a0Pub Health (oxf)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/acr.22160","article-title":"Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional study","volume":"66","author":"Xu","year":"2014","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193489","article-title":"Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)","volume":"13","author":"Shi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.04.026_bib32","first-page":"4","article-title":"The economic burden of ACPA-positive status among patients with rheumatoid arthritis","volume":"24","author":"Shafrin","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2019.04.026_bib33","first-page":"344","article-title":"Economic burden of patients with inadequate response to targeted immunomodulators for rheumatoid arthritis","volume":"24","author":"Strand","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2019.04.026_bib34","first-page":"1","article-title":"The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients","author":"Shahabi","year":"2019","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.clinthera.2019.04.026_bib35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinthera.2016.03.013","article-title":"Economic burden and treatment patterns of cycling between conventional synthetic disease-modifying antirheumatic drugs among biologic-treated patients with rheumatoid arthritis","volume":"38","author":"Betts","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib36","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/acr.22824","article-title":"Unraveling patient-preferred health and treatment outcomes in early rheumatoid arthritis: a longitudinal qualitative study","volume":"68","author":"van der Elst","year":"2016","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib37","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/art.39079","article-title":"Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D","volume":"67","author":"Yazdany","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib38","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.171339","article-title":"Association of medication beliefs, self-efficacy, and adherence in a diverse cohort of adults with rheumatoid arthritis","volume":"45","author":"McCulley","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/acr.23301","article-title":"Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens","volume":"70","author":"Shaw","year":"2018","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","article-title":"What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review","volume":"73","author":"van Nies","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/annrheumdis-2014-206047","article-title":"Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and ESPOIR cohorts","volume":"74","author":"van Nies","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2019.04.026_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib43","first-page":"Sp315","article-title":"Two-year adherence and costs for biologic therapy for rheumatoid arthritis","volume":"24","author":"Stolshek","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2019.04.026_bib44","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s10067-017-3958-1","article-title":"High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis","volume":"37","author":"Kuusalo","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2019.04.026_bib45","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/rheumatology\/kex352","article-title":"Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study","volume":"56","author":"Raheel","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21710","article-title":"The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis","volume":"21","author":"Wailoo","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2019.04.026_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/acr.22722","article-title":"Prednisone use and risk of mortality in patients with rheumatoid arthritis: moderation by use of disease-modifying antirheumatic drugs","volume":"68","author":"Chester Wasko","year":"2016","journal-title":"Arthritis Care Res (hoboken)"},{"key":"10.1016\/j.clinthera.2019.04.026_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.clinthera.2019.04.020","article-title":"Potential pharmacological targets for the prevention of rheumatoid arthritis","volume":"41","author":"Isaacs","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib49","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.clinthera.2019.04.017","article-title":"Predicting rheumatoid arthritis in at-risk individuals","volume":"41","author":"van Boheemen","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib50","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinthera.2019.04.021","article-title":"Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure?","volume":"41","author":"Zaccardelli","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2019.04.026_bib51","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.clinthera.2019.04.014","article-title":"Considerations for optimal trial design for rheumatoid arthritis prevention studies","volume":"41","author":"Cope","year":"2019","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819301900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:04Z","timestamp":1758963004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819301900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0149291819301900"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.026","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatoid Arthritis: A Severe Disease That Preventive Approaches Would Greatly Benefit","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}